Biomark Diagnostics Inc. BMKDF
0.34 USD 0.00 (+0.00%)
At close·Nov 2, 2026, 4:00 PM EST
0.2259 52-week range 0.5044
- YTD
- -2.07%
- 1 year
- +39.86%
Altman Z-Score
5.07 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -43.1×
P/S 1068×
P/B 193×
P/FCF -58.4×
EV/EBITDA -62.0×
EV/Sales 1070×
FCF Yield -1.7%
Gross Margin 100.0%
Operating Margin -2436.8%
Net Margin -2470.8%
ROE -446.2%
ROIC -138.0%
ROA -79.4%
Revenue -61.2%
Operating Income 23.6%
EPS (diluted) 29.5%
Free Cash Flow 0.3%
Current Ratio 1.0×
Quick Ratio 1.0×
Debt / Equity 2.2×
Net Debt / EBITDA -0.1×
Interest Coverage -23.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-03-31